Dyskinesia in multiple system atrophy and progressive supranuclear palsy

J Neural Transm (Vienna). 2019 Jul;126(7):925-932. doi: 10.1007/s00702-019-02012-0. Epub 2019 May 13.

Abstract

In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of L-Dopa-induced dyskinesia (LID) is considered a supportive criterion. This implies that in the presence of LID an atypical Parkinson-syndrome (APS) is unlikely. However, dyskinesia, and in particular LID, can also be present in APS such as MSA and PSP, although less frequently, and with varying clinical appearance. We conclude that whilst presence of dyskinesia provides support for a diagnosis of IPD, they do not allow reliable differentiation from APS.

Keywords: Dyskinesia; Multiple system atrophy; Parkinson’s disease; Progressive supranuclear palsy.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Dyskinesia, Drug-Induced / etiology
  • Dyskinesias / etiology*
  • Humans
  • Levodopa / adverse effects
  • Multiple System Atrophy / complications*
  • Multiple System Atrophy / diagnosis
  • Parkinson Disease / complications*
  • Parkinson Disease / diagnosis
  • Parkinson Disease / drug therapy
  • Supranuclear Palsy, Progressive / complications*
  • Supranuclear Palsy, Progressive / diagnosis

Substances

  • Levodopa